Is It Too Late to Buy AbbVie Stock?

Is It Too Late to Buy AbbVie Stock?

Pharma giant AbbVie (NYSE: ABBV) has rewarded shareholders in the past decade with market-beating performance. AbbVie's strong showing was primarily a result of its top-selling drug, Humira. If the company manages to replace the medicine, it could deliver many more years of solid performances.